Ferring Pharmaceuticals

This study tests a gene therapy called nadofaragene firadenovec against simply watching and waiting in people with intermediate-risk non-muscle invasive bladder cancer. About 454 participants will receive either the treatment or observation after standard surgery. The goal is to …

This early-stage trial tests a gene therapy drug (nadofaragene firadenovec) that is instilled directly into the kidney's drainage system. It aims to treat low-grade upper tract urothelial cancer without major surgery. About 20 adults with confirmed low-grade tumors will receive t…

This phase 3 trial tests a gene therapy called nadofaragene firadenovec, given directly into the bladder, either alone or with chemotherapy or immunotherapy. It is for people with a type of bladder cancer (non-muscle invasive) that has not responded to standard BCG therapy. The s…

This study tests a medicine called CLENPIQ to clean the bowels of children aged 2 to 9 before a colonoscopy. About 30 children will take part to see if the medicine works well and is safe. The goal is to make the prep easier and more effective for kids.

This study will follow about 2,500 Chinese women who are using the fertility drug REKOVELLE for the first time during IVF or ICSI treatments. Researchers want to see how well the drug works in everyday medical practice, including live birth rates and safety. The study does not te…